Evaluation of Rapid Onset of Action of ICS/LABA Combination Therapies on Respiratory Function in Asthma Patients: A Single-Center, Open-Label, Randomized, Crossover Trial.
Hiroyuki OhbayashiSahori KudoMitsue ArigaPublished in: Pulmonary therapy (2018)
Kyorin Pharmaceutical Co., Ltd.
Keyphrases
- open label
- phase iii
- phase ii
- clinical trial
- end stage renal disease
- double blind
- study protocol
- placebo controlled
- ejection fraction
- newly diagnosed
- chronic kidney disease
- phase ii study
- peritoneal dialysis
- chronic obstructive pulmonary disease
- prognostic factors
- squamous cell carcinoma
- lung function
- cystic fibrosis
- air pollution